Antihypertensive pharmacogenetic effect of fibrinogen-beta variant -455G>A on cardiovascular disease, end-stage renal disease, and mortality: the GenHAT study. [electronic resource]
Producer: 20090909Description: 415-21 p. digitalISSN:- 1744-6872
- Aged
- Amlodipine -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Antihypertensive Agents -- therapeutic use
- Calcium Channel Blockers -- therapeutic use
- Chlorthalidone -- therapeutic use
- Coronary Disease -- genetics
- Diuretics -- therapeutic use
- Fibrinogen -- genetics
- Genetic Variation
- Genotype
- Humans
- Hypertension -- drug therapy
- Kidney Failure, Chronic -- genetics
- Lisinopril -- therapeutic use
- Middle Aged
- Stroke -- complications
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.